CHADS2 Score - Stroke Risk Assessment, and Antithrombotic Therapy

Stroke Risk Assessment, and Antithrombotic Therapy

Annual Stroke Risk
CHADS2 Score Stroke Risk % 95% CI
0
1.9
1.2–3.0
1
2.8
2.0–3.8
2
4.0
3.1–5.1
3
5.9
4.6–7.3
4
8.5
6.3–11.1
5
12.5
8.2–17.5
6
18.2
10.5–27.4

According to the findings of the initial validation study, the risk of stroke as a percentage per year for the CHADS2 score is shown in the table.

The CHADS2 score does not include some common stroke risk factors and its various pros/cons have been carefully discussed. Nonetheless, this score is simple and thus it has become widely used.

To complement the CHADS2 score, by the inclusion of additional 'stroke risk modifier' risk factors, the CHA2DS2-VASc score has been proposed. These additional non-major stroke risk factors include age 65-74, female gender and vascular disease. In the CHA2DS2-VASc score score, 'age 75 and above' also has extra weight, with 2 points.

The CHA2DS2-VASc score has been used in the new European Society of Cardiology guidelines for the management of atrial fibrillation.

The European Society of Cardiology (ESC) guidelines recommend that if the patient has a CHADS2 score of 2 and above, oral anticoagulation therapy (OAC) such as warfarin (target INR of 2-3) or one of the new OAC drugs (such as dabigatran) should be prescribed.

If the CHADS2 score is 0-1, other stroke risk modifiers could be considered: (i) If there are 2 or more risk factors (essentially a CHA2DS2-VASc score score of 2 or more), OAC is recommended; and (ii) If there is 1 risk factor (essentially a CHA2DS2-VASc score score=1), antithrombotic therapy with OAC or aspirin (OAC preferred) is recommended, and patient values and preferences should be considered.

A CHA2DS2-VASc score score=0 corresponds to a 'truly low risk,’ and thus the recommendation is to prescribe either aspirin or no antithrombotic therapy, but 'no antithrombotic therapy' is preferred.

Stroke risk assessment should always include an assessment of bleeding risk. This can be done using validated bleeding risk scores, such as the HEMORR2HAGES or HAS-BLED scores. The latter is recommended in the ESC and Canadian guidelines. If the patient is taking warfarin, then knowledge of INR control is needed to assess the 'labile INR' criterion in HAS-BLED; otherwise for a non-warfarin patient, this scores zero.

Read more about this topic:  CHADS2 Score

Famous quotes containing the words stroke, risk and/or therapy:

    We are double-edged blades, and every time we whet our virtue the return stroke straps our vice. Where is the skillful swordsman who can give clean wounds, and not rip up his work with the other edge?
    Henry David Thoreau (1817–1862)

    Men’s hearts are cold. They are indifferent. Not all the coal that is dug warms the world. It remains indifferent to the lives of those who risk their life and health down in the blackness of the earth; who crawl through dark, choking crevices with only a bit of lamp on their caps to light their silent way; whose backs are bent with toil, whose very bones ache, whose happiness is sleep, and whose peace is death.
    Mother Jones (1830–1930)

    Show business is the best possible therapy for remorse.
    Anita Loos (1888–1981)